In a 49-year-old HIV-positive man with acute severe anemia and suspected parvovirus B19 infection, what therapeutic intervention is most likely to be effective?

Intravenous Gamma-Globulin (IVIG) is the Most Appropriate Treatment

For this HIV-positive patient with acute severe anemia and suspected parvovirus B19 infection (based on exposure to children with "slapped-cheek" rash), initiation of intravenous gamma-globulin is the most likely therapeutic intervention to treat his acute anemia.

Clinical Reasoning

Diagnosis: Parvovirus B19-Induced Transient Aplastic Crisis

The clinical picture strongly suggests parvovirus B19 infection causing pure red cell aplasia:

• Severe acute anemia (hemoglobin dropped from 12.8 to 6 g/dL)
• Exposure history to children with classic "slapped-cheek" appearance (erythema infectiosum)
• Normal biochemical markers (normal LDH, haptoglobin, liver function) ruling out hemolysis
• No evidence of blood loss (negative stool occult blood)
• HIV infection with immunosuppression increases risk for chronic parvovirus infection

Parvovirus B19 specifically targets erythroid progenitor cells, causing transient aplastic crisis characterized by severe anemia with markedly decreased reticulocyte count (typically <1%) 1. In immunocompromised HIV patients who cannot mount adequate neutralizing antibody responses, this infection becomes chronic and causes pure red cell aplasia 2, 3, 4.

Why IVIG is the Correct Answer

IVIG provides passive neutralizing antibodies that the patient cannot produce himself, directly addressing the underlying pathophysiology 4, 5. Multiple recent case reports demonstrate:

• Rapid resolution of anemia following IVIG administration 2, 3, 6, 5
• Restoration of erythropoiesis and reticulocyte production 6, 5
• Elimination of transfusion dependence 7
• Excellent therapeutic response even in severely immunosuppressed patients 2, 8

The diagnosis is confirmed by detecting parvovirus B19 DNA via PCR in the absence of IgG antibody, or with non-neutralizing IgG present 4.

Why Other Options Are Incorrect

A) Discontinuation of Vitamin C

While chronic vitamin C supplementation can theoretically worsen iron overload in patients with hemolytic anemias, this patient has:

• Normal hemolysis markers (normal LDH, haptoglobin)
• No evidence of iron overload
• Acute onset anemia, not chronic hemolysis

Stopping vitamin C would not address parvovirus-induced red cell aplasia.

B) Initiation of Erythropoietin

Erythropoietin is ineffective in parvovirus B19 infection because:

• The virus directly destroys erythroid progenitor cells 1
• No target cells exist for erythropoietin to stimulate
• Bone marrow shows absence of red cell precursors or giant pronormoblasts 4
• Endogenous erythropoietin levels are already elevated in response to anemia

C) Discontinuation of Antiretrovirals

This would be dangerous and counterproductive:

• The patient has an undetectable viral load on stable ART for 3 years - this is optimal HIV control
• Stopping ART would worsen immunosuppression, making parvovirus infection worse 8
• Modern ART regimens (not zidovudine-based) rarely cause significant anemia
• Guidelines emphasize continuing effective ART in HIV patients with opportunistic infections 9

D) Initiation of Corticosteroids

Corticosteroids would:

• Further suppress the immune system
• Worsen the patient's inability to clear parvovirus infection
• Have no role in treating parvovirus-induced pure red cell aplasia
• Potentially increase viral replication

Clinical Management Algorithm

1. Confirm diagnosis: Check parvovirus B19 DNA by PCR and anti-B19 IgG/IgM serology 4
2. Assess reticulocyte count: Expect marked reticulocytopenia (<1%) 1
3. Provide supportive care: Red cell transfusion if symptomatic or hemoglobin <7 g/dL 1
4. Administer IVIG: Standard dosing (typically 0.4 g/kg/day for 5 days or 1-2 g/kg as single dose) 2, 6, 5
5. Continue ART: Maintain current antiretroviral regimen 8
6. Monitor response: Check hemoglobin and reticulocyte count weekly initially 6
7. Consider maintenance IVIG: If anemia recurs despite immune reconstitution, monthly maintenance may be needed 2, 4

Important Caveats

• Isolation precautions: Parvovirus is highly contagious; isolate from pregnant healthcare workers and other immunocompromised individuals 1
• Screen contacts: Siblings and household contacts with chronic hemolysis or immunosuppression are at risk 1
• Monitor for relapse: Some patients require repeated IVIG doses or maintenance therapy if immunosuppression persists 2, 4
• Bone marrow biopsy: May be needed if diagnosis remains uncertain, showing giant pronormoblasts or absent red cell precursors 4, 5